Where do the fattest Germans live?

December 12, 2008

The population of the federal state of Saxony-Anhalt most often suffers from obesity and has the greatest waist circumference, followed by Brandenburg. Hans Hauner of Munich Technical University and his coauthors have performed a study of the regional differences in prevalence in general medical care. Their results are reported in the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2008; 105[48]: 827-33).

http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=62526

The study found that the mean prevalence of obesity was 22.8%, with a maximum in Saxony-Anhalt (28.3%) and a minimum in Bremen (19.8%). Persons with a body-mass index (weight/height2) above 30 are regarded as obese. The mean prevalence of increased waist circumference was 36.5%, with a maximum in Saxony-Anhalt (42.1%) and a minimum in Hamburg (30.5%). Waist circumference above 88 cm in women and above 102 cm in men is regarded as increased. 50% of obese patients and 32% of patients with increased waist circumference suffered from type 2 diabetes. The authors based their results on an analysis of the data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). A total of 1511 practices and 35 869 patients took part in this study.

As habits and socioeconomic conditions vary within Germany, the authors emphasize the importance of these data for regional health institutions. Targeted regional intervention strategies are largely lacking. The family doctor/general practitioner is the primary contact within the population and could play a central role in prevention and early recognition in combating obesity.

During the last 20 years, the prevalence of obesity in Germany has increased by 39% in men and 21.2% in women.
-end-


Deutsches Aerzteblatt International

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.